Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Kim

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
European Journal of Neurology|July 5, 2014
Higher C-peptide levels are associated with regional cortical thinning in 1093 cognitively normal subjectsC W Yoon, M Kang, H Y Shin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2023
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung CancerM Altan, F Soto, T Xu, et al.
Oncogene|December 6, 2011
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancerW Liu, J Lindberg, G Sui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>S H Park, D H Lim, T S Sohn, et al.
ESMO Open|August 27, 2022
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort AD V T Catenacci, Y-K Kang, H H Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsS T Kim, K C Banks, E Pectasides, et al.
European Journal of Neurology|February 6, 2014
Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical typeH J Kim, B S Ye, C W Yoon, et al.
Journal of Korean Medical Science|October 20, 2001
Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter studyD Bang, J H Lee, E S Lee, et al.
ESMO Open|May 26, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancerT Yoshino, A Cervantes, H Bando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglectedF Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
European Journal of Neurology|July 5, 2014
Higher C-peptide levels are associated with regional cortical thinning in 1093 cognitively normal subjectsC W Yoon, M Kang, H Y Shin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2023
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung CancerM Altan, F Soto, T Xu, et al.
Oncogene|December 6, 2011
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancerW Liu, J Lindberg, G Sui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>S H Park, D H Lim, T S Sohn, et al.
ESMO Open|August 27, 2022
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort AD V T Catenacci, Y-K Kang, H H Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsS T Kim, K C Banks, E Pectasides, et al.
European Journal of Neurology|February 6, 2014
Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical typeH J Kim, B S Ye, C W Yoon, et al.
Journal of Korean Medical Science|October 20, 2001
Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter studyD Bang, J H Lee, E S Lee, et al.
ESMO Open|May 26, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancerT Yoshino, A Cervantes, H Bando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglectedF Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
Pageof 22